Імуноглобуліни для внутрішньовенного введення (Ukrainian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Імуноглобуліни для внутрішньовенного введення" in Ukrainian language version.

refsWebsite

Global rank Ukrainian rank

29nih.gov

4^th place

5^th place

24doi.org

2^nd place

4^th place

12web.archive.org

1^st place

5archive.org

6^th place

2sorbonne-universite.fr

low place

1drugs.com

399^th place

754^th place

1books.google.com

3^rd place

11^th place

1dynamed.com

low place

1mdanderson.org

low place

1harvard.edu

18^th place

74^th place

1aappublications.org

3,763^rd place

4,710^th place

1nytimes.com

7^th place

43^rd place

1cbsnews.com

108^th place

464^th place

1genengnews.com

low place

1businesswire.com

615^th place

3,471^st place

aappublications.org

pediatrics.aappublications.org

Gern JE (August 2002). Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor. Pediatrics. 110 (2): 467—68. doi:10.1542/peds.110.S2.467a. Архів оригіналу за 11 червня 2008.

archive.org

British national formulary : BNF 69 (вид. 69). British Medical Association. 2015. с. 867–71. ISBN 9780857111562.
Daw Z, Padmore R, Neurath D, Cober N, Tokessy M, Desjardins D, Olberg B, Tinmouth A, Giulivi A (August 2008). Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion. 48 (8): 1598—1601. doi:10.1111/j.1537-2995.2008.01721.x. PMID 18466176.
Nimmerjahn, F; Ravetch, JV (January 2007). The antiinflammatory activity of IgG: the intravenous IgG paradox. The Journal of Experimental Medicine. 204 (1): 11—15. doi:10.1084/jem.20061788. PMC 2118416. PMID 17227911.
Maddur MS, Vani J, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J (March 2011). Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. The Journal of Allergy and Clinical Immunology. 127 (3): 823–30.e1–7. doi:10.1016/j.jaci.2010.12.1102. PMID 21281961.
Clynes R (January 2005). Immune complexes as therapy for autoimmunity. The Journal of Clinical Investigation. 115 (1): 25—27. doi:10.1172/JCI23994. PMC 539209. PMID 15630438.

books.google.com

Etzioni, Amos; Ochs, Hans D. (2014). Primary Immunodeficiency Disorders: A Historic and Scientific Perspective (англ.). Academic Press. с. 283—84. ISBN 9780124115545. Архів оригіналу за 9 січня 2017.

businesswire.com

FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients. www.businesswire.com (англ.). 20 травня 2020. Архів оригіналу за 21 червня 2020. Процитовано 28 травня 2020.

cbsnews.com

Experimental Alzheimer's drug Gammagard may stall memory decline, small study suggests. CBS News. 17 липня 2012. Архів оригіналу за 19 липня 2012. Процитовано 19 липня 2012.

doi.org

Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C (April 2006). Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. The Journal of Allergy and Clinical Immunology (Review). 117 (4 Suppl): S525—S553. doi:10.1016/j.jaci.2006.01.015. PMID 16580469.
van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC (May 2010). IVIG treatment and prognosis in Guillain-Barré syndrome. Journal of Clinical Immunology. 30 (S1): S74—S78. doi:10.1007/s10875-010-9407-4. PMC 2883091. PMID 20396937.
Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Miller RG, Sladky JT, Stevens JC (September 2003). Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 61 (6): 736—740. doi:10.1212/WNL.61.6.736. PMID 14504313.
Pondrom S (October 2014). The IVIg dilemma. The AJT Report. American Journal of Transplantation. 14 (10): 2195—2196. doi:10.1111/ajt.12995. PMID 25231064.
Daw Z, Padmore R, Neurath D, Cober N, Tokessy M, Desjardins D, Olberg B, Tinmouth A, Giulivi A (August 2008). Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion. 48 (8): 1598—1601. doi:10.1111/j.1537-2995.2008.01721.x. PMID 18466176.
Lee Martin N, Butani Lavjay (2005). Intravenous Immunoglobulin (IVIG) in Rheumatologic Diseases: A Review of its Mechanism of Action. Current Rheumatology Reviews. 1 (3): 289—93. doi:10.2174/157339705774612355.
Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (October 1998). Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282 (5388): 490—493. Bibcode:1998Sci...282..490V. doi:10.1126/science.282.5388.490. PMID 9774279.
Gern JE (August 2002). Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor. Pediatrics. 110 (2): 467—68. doi:10.1542/peds.110.S2.467a. Архів оригіналу за 11 червня 2008.
Nimmerjahn, F; Ravetch, JV (January 2007). The antiinflammatory activity of IgG: the intravenous IgG paradox. The Journal of Experimental Medicine. 204 (1): 11—15. doi:10.1084/jem.20061788. PMC 2118416. PMID 17227911.
Galeotti C, Kaveri SV, Bayry J (December 2017). IVIG-mediated effector functions in autoimmune and inflammatory diseases. International Immunology. 29 (11): 491—498. doi:10.1093/intimm/dxx039. PMID 28666326.
Maddur MS, Kaveri SV, Bayry J (November 2017). Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin (PDF). Trends in Immunology. 38 (11): 789—792. doi:10.1016/j.it.2017.08.008. PMID 28916232. Архів (PDF) оригіналу за 1 лютого 2022. Процитовано 12 січня 2022.
Othy S, Topçu S, Saha C, Kothapalli P, Lacroix-Desmazes S, Käsermann F, Miescher S, Bayry J, Kaveri SV (July 2014). Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin. European Journal of Immunology. 44 (7): 2059—2063. doi:10.1002/eji.201444440. PMID 24700174.
Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D, McKenzie BS, Käsermann F (June 2014). Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. Journal of Immunology. 192 (11): 5031—5038. doi:10.4049/jimmunol.1301611. PMC 4025610. PMID 24760152.
Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV (January 2003). Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 101 (2): 758—765. doi:10.1182/blood-2002-05-1447. PMID 12393386.
Das M, Karnam A, Stephen-Victor E, Gilardin L, Bhatt B, Kumar Sharma V, Rambabu N, Patil V, Lecerf M, Käsermann F, Bruneval P, Narayanaswamy Balaji K, Benveniste O, Kaveri SV, Bayry J (January 2020). Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy. Cell Death & Disease. 11 (1): 50. doi:10.1038/s41419-020-2249-y. PMC 6978335. PMID 31974400.
Trinath J, Hegde P, Sharma M, Maddur MS, Rabin M, Vallat JM, Magy L, Balaji KN, Kaveri SV, Bayry J (August 2013). Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood. 122 (8): 1419—1427. doi:10.1182/blood-2012-11-468264. PMID 23847198.
Maddur MS, Vani J, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J (March 2011). Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. The Journal of Allergy and Clinical Immunology. 127 (3): 823–30.e1–7. doi:10.1016/j.jaci.2010.12.1102. PMID 21281961.
Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J (August 2019). Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE (PDF). The Journal of Allergy and Clinical Immunology. 144 (2): 524—535.e8. doi:10.1016/j.jaci.2018.10.064. PMID 30529242. Архів (PDF) оригіналу за 7 березня 2020. Процитовано 8 липня 2022.
Galeotti C, Karnam A, Dimitrov JD, Chevailler A, Kaveri SV, Bayry J (April 2020). Anti-IgE IgG autoantibodies isolated from therapeutic normal IgG intravenous immunoglobulin induce basophil activation. Cellular & Molecular Immunology. 17 (4): 426—429. doi:10.1038/s41423-019-0334-x. PMC 7109030. PMID 31797906.
Clynes R (January 2005). Immune complexes as therapy for autoimmunity. The Journal of Clinical Investigation. 115 (1): 25—27. doi:10.1172/JCI23994. PMC 539209. PMID 15630438.
Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH (June 2006). Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nature Medicine. 12 (6): 688—692. doi:10.1038/nm1416. PMID 16715090.
Bayry J, Thirion M, Misra N, Thorenoor N, Delignat S, Lacroix-Desmazes S, Bellon B, Kaveri S, Kazatchkine MD (October 2003). Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurological Sciences. 24 (Suppl 4): S217—S221. doi:10.1007/s10072-003-0081-7. PMID 14598046.
Janke AD, Yong VW (April 2006). Impact of IVIg on the interaction between activated T cells and microglia. Neurological Research. 28 (3): 270—274. doi:10.1179/016164106X98143. PMID 16687052.
Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV (February 1999). Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. The Journal of Infectious Diseases. 179 (Suppl 1): S218—S223. doi:10.1086/514294. PMID 9988187.

drugs.com

Immune Globulin. The American Society of Health-System Pharmacists. Архів оригіналу за 9 січня 2017. Процитовано 8 січня 2017.

dynamed.com

Immune Globulin. Dynamed. Архів оригіналу за 8 грудня 2015. Процитовано 23 листопада 2015.Шаблон:Subscription or libraries

genengnews.com

Another Alzheimer's Drug Fails Phase III Trial. Архів оригіналу за 7 червня 2013.

harvard.edu

ui.adsabs.harvard.edu

Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (October 1998). Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282 (5388): 490—493. Bibcode:1998Sci...282..490V. doi:10.1126/science.282.5388.490. PMID 9774279.

mdanderson.org

www3.mdanderson.org

Lichtiger, Lichtiger. Laboratory Serologic Problems Associated with Administration of Intravenous IgG. The University of Texas M. D. Anderson Cancer Center. Архів оригіналу за 5 березня 2016. Процитовано 23 листопада 2015.

nih.gov

pubmed.ncbi.nlm.nih.gov

Orange JS, Hossny EM, Weiler CR, Ballow M, Berger M, Bonilla FA, Buckley R, Chinen J, El-Gamal Y, Mazer BD, Nelson RP, Patel DD, Secord E, Sorensen RU, Wasserman RL, Cunningham-Rundles C (April 2006). Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. The Journal of Allergy and Clinical Immunology (Review). 117 (4 Suppl): S525—S553. doi:10.1016/j.jaci.2006.01.015. PMID 16580469.
van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC (May 2010). IVIG treatment and prognosis in Guillain-Barré syndrome. Journal of Clinical Immunology. 30 (S1): S74—S78. doi:10.1007/s10875-010-9407-4. PMC 2883091. PMID 20396937.
Hughes RA, Wijdicks EF, Barohn R, Benson E, Cornblath DR, Hahn AF, Meythaler JM, Miller RG, Sladky JT, Stevens JC (September 2003). Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 61 (6): 736—740. doi:10.1212/WNL.61.6.736. PMID 14504313.
Pondrom S (October 2014). The IVIg dilemma. The AJT Report. American Journal of Transplantation. 14 (10): 2195—2196. doi:10.1111/ajt.12995. PMID 25231064.
Daw Z, Padmore R, Neurath D, Cober N, Tokessy M, Desjardins D, Olberg B, Tinmouth A, Giulivi A (August 2008). Hemolytic transfusion reactions after administration of intravenous immune (gamma) globulin: a case series analysis. Transfusion. 48 (8): 1598—1601. doi:10.1111/j.1537-2995.2008.01721.x. PMID 18466176.
Viard I, Wehrli P, Bullani R, Schneider P, Holler N, Salomon D, Hunziker T, Saurat JH, Tschopp J, French LE (October 1998). Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science. 282 (5388): 490—493. Bibcode:1998Sci...282..490V. doi:10.1126/science.282.5388.490. PMID 9774279.
Nimmerjahn, F; Ravetch, JV (January 2007). The antiinflammatory activity of IgG: the intravenous IgG paradox. The Journal of Experimental Medicine. 204 (1): 11—15. doi:10.1084/jem.20061788. PMC 2118416. PMID 17227911.
Galeotti C, Kaveri SV, Bayry J (December 2017). IVIG-mediated effector functions in autoimmune and inflammatory diseases. International Immunology. 29 (11): 491—498. doi:10.1093/intimm/dxx039. PMID 28666326.
Maddur MS, Kaveri SV, Bayry J (November 2017). Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin (PDF). Trends in Immunology. 38 (11): 789—792. doi:10.1016/j.it.2017.08.008. PMID 28916232. Архів (PDF) оригіналу за 1 лютого 2022. Процитовано 12 січня 2022.
Othy S, Topçu S, Saha C, Kothapalli P, Lacroix-Desmazes S, Käsermann F, Miescher S, Bayry J, Kaveri SV (July 2014). Sialylation may be dispensable for reciprocal modulation of helper T cells by intravenous immunoglobulin. European Journal of Immunology. 44 (7): 2059—2063. doi:10.1002/eji.201444440. PMID 24700174.
Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D, McKenzie BS, Käsermann F (June 2014). Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. Journal of Immunology. 192 (11): 5031—5038. doi:10.4049/jimmunol.1301611. PMC 4025610. PMID 24760152.
Bayry J, Lacroix-Desmazes S, Carbonneil C, Misra N, Donkova V, Pashov A, Chevailler A, Mouthon L, Weill B, Bruneval P, Kazatchkine MD, Kaveri SV (January 2003). Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin. Blood. 101 (2): 758—765. doi:10.1182/blood-2002-05-1447. PMID 12393386.
Das M, Karnam A, Stephen-Victor E, Gilardin L, Bhatt B, Kumar Sharma V, Rambabu N, Patil V, Lecerf M, Käsermann F, Bruneval P, Narayanaswamy Balaji K, Benveniste O, Kaveri SV, Bayry J (January 2020). Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy. Cell Death & Disease. 11 (1): 50. doi:10.1038/s41419-020-2249-y. PMC 6978335. PMID 31974400.
Trinath J, Hegde P, Sharma M, Maddur MS, Rabin M, Vallat JM, Magy L, Balaji KN, Kaveri SV, Bayry J (August 2013). Intravenous immunoglobulin expands regulatory T cells via induction of cyclooxygenase-2-dependent prostaglandin E2 in human dendritic cells. Blood. 122 (8): 1419—1427. doi:10.1182/blood-2012-11-468264. PMID 23847198.
Maddur MS, Vani J, Hegde P, Lacroix-Desmazes S, Kaveri SV, Bayry J (March 2011). Inhibition of differentiation, amplification, and function of human TH17 cells by intravenous immunoglobulin. The Journal of Allergy and Clinical Immunology. 127 (3): 823–30.e1–7. doi:10.1016/j.jaci.2010.12.1102. PMID 21281961.
Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J (August 2019). Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE (PDF). The Journal of Allergy and Clinical Immunology. 144 (2): 524—535.e8. doi:10.1016/j.jaci.2018.10.064. PMID 30529242. Архів (PDF) оригіналу за 7 березня 2020. Процитовано 8 липня 2022.
Galeotti C, Karnam A, Dimitrov JD, Chevailler A, Kaveri SV, Bayry J (April 2020). Anti-IgE IgG autoantibodies isolated from therapeutic normal IgG intravenous immunoglobulin induce basophil activation. Cellular & Molecular Immunology. 17 (4): 426—429. doi:10.1038/s41423-019-0334-x. PMC 7109030. PMID 31797906.
Clynes R (January 2005). Immune complexes as therapy for autoimmunity. The Journal of Clinical Investigation. 115 (1): 25—27. doi:10.1172/JCI23994. PMC 539209. PMID 15630438.
Siragam V, Crow AR, Brinc D, Song S, Freedman J, Lazarus AH (June 2006). Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nature Medicine. 12 (6): 688—692. doi:10.1038/nm1416. PMID 16715090.
Bayry J, Thirion M, Misra N, Thorenoor N, Delignat S, Lacroix-Desmazes S, Bellon B, Kaveri S, Kazatchkine MD (October 2003). Mechanisms of action of intravenous immunoglobulin in autoimmune and inflammatory diseases. Neurological Sciences. 24 (Suppl 4): S217—S221. doi:10.1007/s10072-003-0081-7. PMID 14598046.
Janke AD, Yong VW (April 2006). Impact of IVIg on the interaction between activated T cells and microglia. Neurological Research. 28 (3): 270—274. doi:10.1179/016164106X98143. PMID 16687052.
Kudoyarova-Zubavichene NM, Sergeyev NN, Chepurnov AA, Netesov SV (February 1999). Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections. The Journal of Infectious Diseases. 179 (Suppl 1): S218—S223. doi:10.1086/514294. PMID 9988187.

ncbi.nlm.nih.gov

van Doorn PA, Kuitwaard K, Walgaard C, van Koningsveld R, Ruts L, Jacobs BC (May 2010). IVIG treatment and prognosis in Guillain-Barré syndrome. Journal of Clinical Immunology. 30 (S1): S74—S78. doi:10.1007/s10875-010-9407-4. PMC 2883091. PMID 20396937.
Nimmerjahn, F; Ravetch, JV (January 2007). The antiinflammatory activity of IgG: the intravenous IgG paradox. The Journal of Experimental Medicine. 204 (1): 11—15. doi:10.1084/jem.20061788. PMC 2118416. PMID 17227911.
Campbell IK, Miescher S, Branch DR, Mott PJ, Lazarus AH, Han D, Maraskovsky E, Zuercher AW, Neschadim A, Leontyev D, McKenzie BS, Käsermann F (June 2014). Therapeutic effect of IVIG on inflammatory arthritis in mice is dependent on the Fc portion and independent of sialylation or basophils. Journal of Immunology. 192 (11): 5031—5038. doi:10.4049/jimmunol.1301611. PMC 4025610. PMID 24760152.
Das M, Karnam A, Stephen-Victor E, Gilardin L, Bhatt B, Kumar Sharma V, Rambabu N, Patil V, Lecerf M, Käsermann F, Bruneval P, Narayanaswamy Balaji K, Benveniste O, Kaveri SV, Bayry J (January 2020). Intravenous immunoglobulin mediates anti-inflammatory effects in peripheral blood mononuclear cells by inducing autophagy. Cell Death & Disease. 11 (1): 50. doi:10.1038/s41419-020-2249-y. PMC 6978335. PMID 31974400.
Galeotti C, Karnam A, Dimitrov JD, Chevailler A, Kaveri SV, Bayry J (April 2020). Anti-IgE IgG autoantibodies isolated from therapeutic normal IgG intravenous immunoglobulin induce basophil activation. Cellular & Molecular Immunology. 17 (4): 426—429. doi:10.1038/s41423-019-0334-x. PMC 7109030. PMID 31797906.
Clynes R (January 2005). Immune complexes as therapy for autoimmunity. The Journal of Clinical Investigation. 115 (1): 25—27. doi:10.1172/JCI23994. PMC 539209. PMID 15630438.

dailymed.nlm.nih.gov

Hyqvia (immune globulin 10 percent- human with recombinant human hyaluronidase) kit. DailyMed. Архів оригіналу за 5 серпня 2020. Процитовано 1 травня 2020.

nytimes.com

Andrew Pollack (17 липня 2012). Small Trial Hints Drug Can Slow Alzheimer's. New York Times. Архів оригіналу за 19 липня 2012. Процитовано 19 липня 2012.

sorbonne-universite.fr

hal.sorbonne-universite.fr

Maddur MS, Kaveri SV, Bayry J (November 2017). Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin (PDF). Trends in Immunology. 38 (11): 789—792. doi:10.1016/j.it.2017.08.008. PMID 28916232. Архів (PDF) оригіналу за 1 лютого 2022. Процитовано 12 січня 2022.
Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J (August 2019). Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE (PDF). The Journal of Allergy and Clinical Immunology. 144 (2): 524—535.e8. doi:10.1016/j.jaci.2018.10.064. PMID 30529242. Архів (PDF) оригіналу за 7 березня 2020. Процитовано 8 липня 2022.

web.archive.org

Immune Globulin. The American Society of Health-System Pharmacists. Архів оригіналу за 9 січня 2017. Процитовано 8 січня 2017.
Etzioni, Amos; Ochs, Hans D. (2014). Primary Immunodeficiency Disorders: A Historic and Scientific Perspective (англ.). Academic Press. с. 283—84. ISBN 9780124115545. Архів оригіналу за 9 січня 2017.
Immune Globulin. Dynamed. Архів оригіналу за 8 грудня 2015. Процитовано 23 листопада 2015.Шаблон:Subscription or libraries
Hyqvia (immune globulin 10 percent- human with recombinant human hyaluronidase) kit. DailyMed. Архів оригіналу за 5 серпня 2020. Процитовано 1 травня 2020.
Lichtiger, Lichtiger. Laboratory Serologic Problems Associated with Administration of Intravenous IgG. The University of Texas M. D. Anderson Cancer Center. Архів оригіналу за 5 березня 2016. Процитовано 23 листопада 2015.
Gern JE (August 2002). Antiinflammatory Activity of IVIG Mediated through the Inhibitory FC Receptor. Pediatrics. 110 (2): 467—68. doi:10.1542/peds.110.S2.467a. Архів оригіналу за 11 червня 2008.
Maddur MS, Kaveri SV, Bayry J (November 2017). Circulating Normal IgG as Stimulator of Regulatory T Cells: Lessons from Intravenous Immunoglobulin (PDF). Trends in Immunology. 38 (11): 789—792. doi:10.1016/j.it.2017.08.008. PMID 28916232. Архів (PDF) оригіналу за 1 лютого 2022. Процитовано 12 січня 2022.
Galeotti C, Stephen-Victor E, Karnam A, Das M, Gilardin L, Maddur MS, Wymann S, Vonarburg C, Chevailler A, Dimitrov JD, Benveniste O, Bruhns P, Kaveri SV, Bayry J (August 2019). Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE (PDF). The Journal of Allergy and Clinical Immunology. 144 (2): 524—535.e8. doi:10.1016/j.jaci.2018.10.064. PMID 30529242. Архів (PDF) оригіналу за 7 березня 2020. Процитовано 8 липня 2022.
Andrew Pollack (17 липня 2012). Small Trial Hints Drug Can Slow Alzheimer's. New York Times. Архів оригіналу за 19 липня 2012. Процитовано 19 липня 2012.
Experimental Alzheimer's drug Gammagard may stall memory decline, small study suggests. CBS News. 17 липня 2012. Архів оригіналу за 19 липня 2012. Процитовано 19 липня 2012.
Another Alzheimer's Drug Fails Phase III Trial. Архів оригіналу за 7 червня 2013.
FDA Approves Octapharma USA Investigational New Drug Application for Severe COVID-19 Patients. www.businesswire.com (англ.). 20 травня 2020. Архів оригіналу за 21 червня 2020. Процитовано 28 травня 2020.